These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17615157)
1. Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways. Ono H; Sakoda H; Fujishiro M; Anai M; Kushiyama A; Fukushima Y; Katagiri H; Ogihara T; Oka Y; Kamata H; Horike N; Uchijima Y; Kurihara H; Asano T Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1576-85. PubMed ID: 17615157 [TBL] [Abstract][Full Text] [Related]
2. Akt-interacting proteins: attractive opposites. focus on "Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways". Franke TF Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1768-70. PubMed ID: 17913839 [No Abstract] [Full Text] [Related]
3. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation. Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758 [TBL] [Abstract][Full Text] [Related]
4. Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer. Liu YP; Liao WC; Ger LP; Chen JC; Hsu TI; Lee YC; Chang HT; Chen YC; Jan YH; Lee KH; Zeng YH; Hsiao M; Lu PJ Cancer Res; 2013 Oct; 73(20):6194-205. PubMed ID: 23943800 [TBL] [Abstract][Full Text] [Related]
5. New players in high fat diet-induced obesity: LETM1 and CTMP. Park J; Li Y; Kim SH; Yang KJ; Kong G; Shrestha R; Tran Q; Park KA; Jeon J; Hur GM; Lee CH; Kim DH; Park J Metabolism; 2014 Mar; 63(3):318-27. PubMed ID: 24333006 [TBL] [Abstract][Full Text] [Related]
6. Use of Akt inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake. Green CJ; Göransson O; Kular GS; Leslie NR; Gray A; Alessi DR; Sakamoto K; Hundal HS J Biol Chem; 2008 Oct; 283(41):27653-27667. PubMed ID: 18669636 [TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694 [TBL] [Abstract][Full Text] [Related]
8. The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death. Miyawaki T; Ofengeim D; Noh KM; Latuszek-Barrantes A; Hemmings BA; Follenzi A; Zukin RS Nat Neurosci; 2009 May; 12(5):618-26. PubMed ID: 19349976 [TBL] [Abstract][Full Text] [Related]
9. Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. Sakoda H; Gotoh Y; Katagiri H; Kurokawa M; Ono H; Onishi Y; Anai M; Ogihara T; Fujishiro M; Fukushima Y; Abe M; Shojima N; Kikuchi M; Oka Y; Hirai H; Asano T J Biol Chem; 2003 Jul; 278(28):25802-7. PubMed ID: 12734207 [TBL] [Abstract][Full Text] [Related]
10. Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that sensitizes cells to apoptosis. Parcellier A; Tintignac LA; Zhuravleva E; Cron P; Schenk S; Bozulic L; Hemmings BA Cell Signal; 2009 Apr; 21(4):639-50. PubMed ID: 19168129 [TBL] [Abstract][Full Text] [Related]
11. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Maira SM; Galetic I; Brazil DP; Kaech S; Ingley E; Thelen M; Hemmings BA Science; 2001 Oct; 294(5541):374-80. PubMed ID: 11598301 [TBL] [Abstract][Full Text] [Related]
12. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss. Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726 [TBL] [Abstract][Full Text] [Related]
13. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle. Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186 [TBL] [Abstract][Full Text] [Related]
14. Sevoflurane preconditioning-induced neuroprotection is associated with Akt activation via carboxy-terminal modulator protein inhibition. Chen Y; Nie H; Tian L; Tong L; Deng J; Zhang Y; Dong H; Xiong L Br J Anaesth; 2015 Feb; 114(2):327-35. PubMed ID: 25182017 [TBL] [Abstract][Full Text] [Related]
15. Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. Misra UK; Deedwania R; Pizzo SV J Biol Chem; 2006 May; 281(19):13694-13707. PubMed ID: 16543232 [TBL] [Abstract][Full Text] [Related]
17. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907 [TBL] [Abstract][Full Text] [Related]
18. Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions. Walter PL; Kampkötter A; Eckers A; Barthel A; Schmoll D; Sies H; Klotz LO Arch Biochem Biophys; 2006 Oct; 454(2):107-13. PubMed ID: 16973122 [TBL] [Abstract][Full Text] [Related]
19. Krüppel-like factor 14 increases insulin sensitivity through activation of PI3K/Akt signal pathway. Yang M; Ren Y; Lin Z; Tang C; Jia Y; Lai Y; Zhou T; Wu S; Liu H; Yang G; Li L Cell Signal; 2015 Nov; 27(11):2201-8. PubMed ID: 26226221 [TBL] [Abstract][Full Text] [Related]
20. Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma. Simon PO; McDunn JE; Kashiwagi H; Chang K; Goedegebuure PS; Hotchkiss RS; Hawkins WG Int J Cancer; 2009 Aug; 125(4):942-51. PubMed ID: 19405118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]